Kann Hansen Medical die neue Intuitive Surgical werden - 500 Beiträge pro Seite

[renuener]

http://www.hansenmedical.com

Hansen Medical (WKN A0LHLD) ist führend in der Entwicklung von offenen Plattformen für den minimal invasiven Eingriff am Herzen und anderen Organen. Durch einen flexiblen Katheter können Operationen ohne den ganzen Brustkorb öffnen zu müssen durchgeführt werden. Dadurch werden nicht nur ästhetische Schäden vermieden sondern auch die Heilungsdauer beschleunigt und das Risiko einer Krankenhaus Infektion dramatisch verringert. Ein bildgebenes Verfahren sorgt dafür, dass der Arzt am Monitor die Operation steuern kann. Als weitere Einsatzbereiche werden Darm- und Magenerkrankungen anvisiert. Durch bestehende Patente ist man praktisch unangreifbar, um Marktführer bei flexiblen, minimal invasiven Operations-Robotersystemen mit einem möglichst breitem Anwendungsbereich zu werden. Aber auch eine Übernahme durch Intuitive Surgical (beide haben den gleichen Gründer) ist nicht unwahrscheinlich. Intuitive ist mit einer Marktkap. von 10,7 Mrd $ etwa 18 mal so groß wie Hansen mit 600 Mio $.

Hansen Medical Chart:



Intuitive Surgical Chart:

[renuener]

Hansen Medical Receives FDA Clearance for Commercialization of Its First Generation Robotic Platform for Catheter Mapping Procedures
New Technology Now Available for Patients Suffering From Cardiac Arrhythmias

MOUNTAIN VIEW, CA, May 03, 2007 (MARKET WIRE via COMTEX News Network) -- Hansen Medical, Inc. (NASDAQ: HNSN) announced today that it has obtained U.S. Food & Drug Administration (FDA) clearance for commercialization of the Sensei(TM) Robotic Catheter System and Artisan(TM) Control Catheter to facilitate manipulation, positioning and control of mapping catheters during electrophysiology (EP) procedures.
The clearance allows physicians to use Hansen Medical's first generation robotic platform to easily place mapping catheters in hard-to-reach anatomical locations within the heart and maintain catheter stability during the diagnostic phase of complex cardiac arrhythmia treatment. Physicians who have used this product for EP procedures say the Sensei system has the potential to change the way cardiac procedures are performed to a more standard approach for complex diseases.

"Hansen Medical is very pleased with the FDA's clearance for the Sensei system, particularly since we previously projected that this clearance would be granted in the second half of 2007," said Frederic Moll, M.D., founder and chief executive officer of Hansen Medical, Inc. "Our direct sales force coupled with our clinical applications specialists can now initiate the sales process and leverage the relationships they have established with leading hospitals throughout the country."

"By offering physicians the freedom to extend their reach into areas of the heart through a robotically controlled catheter that offers instinctive and deliberate catheter guidance, we believe we can ultimately help physicians to better perform complex catheter procedures and contribute to the successful diagnosis of life threatening cardiac diseases," continued Dr. Moll.

SOURCE: Hansen Medical, Inc.